Mark Bodmer
14Patents
9h-index
30Co-inventors
72Inventor score
Filing activity: Jul 3, 1989 → Nov 15, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5677425A | Recombinant antibody | Emerging Cross-Sectional Technologies | 323 | Expired |
| US5877293A | CDR grafted anti-CEA antibodies and their production | Chemistry; Metallurgy | 231 | Expired |
| US6180377A | Humanized antibodies | Chemistry; Metallurgy | 216 | Expired |
| US5219996A | Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules | Emerging Cross-Sectional Technologies | 148 | Expired |
| US5994510A | Recombinant antibodies specific for TNF.alpha. | Chemistry; Metallurgy | 137 | Expired |
| US5958413A | Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor | Human Necessities | 85 | Expired |
| US5965405A | Method for producing Fv fragments in eukaryotic cells | Chemistry; Metallurgy | 15 | Expired |
| US5998586A | Interleukin-5 specific recombinant antibodies | Chemistry; Metallurgy | 12 | Expired |
| US6013642A | Use of estrone derivatives as steroid sulphatase inhibitors | Human Necessities | 9 | Expired |
| US6734286B2 | Interleukin-5 specific recombinant antibodies | Chemistry; Metallurgy | 8 | Expired |
| US6316227A | Nucleic acids encoding interleukin-5 specific recombinant antibodies | Chemistry; Metallurgy | 8 | Expired |
| US6315999A | Pharmaceutical product for the treatment of sepsis | Emerging Cross-Sectional Technologies | 5 | Expired |
| USRE39548E1 | Interleukin-5 specific recombinant antibodies | General | 3 | Expired |
| US11266700B2 | Compositions and methods for treating immune disorders using immune modulating Lactococcus bacteria strains | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.